AI assistant
INSMED Inc — Director's Dealing 2017
Jun 7, 2017
30150_dirs_2017-06-07_0e7618f5-4f11-4d36-86d7-3556690ebeff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2017-06-05
Reporting Person: STRECK PAUL (Chief Medical Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-06-05 | Stock Option | $15.38 | A | 109210 | Acquired | 2027-06-05 | Common Stock (109210) | Direct |
Footnotes
F1: In connection with the appointment of Dr. Streck as the Company's Chief Medical Officer, the Company granted Dr. Streck an option to purchase a total of 109,210 shares of the Company's common stock. The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Dr. Streck's continued employment with the Company on each vesting date.